Skip to content

Clinical trials

Phase 2 Inflammation trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 2 Country / region: United States Clear all

170 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20027
20032
20044
20055
20065
20076
20083
200910
20103
20114
20126
20137
201410
20157
20168
20174
201812
20195
20208
20217
20225
20236
20247
20258
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed103
Terminated25
Recruiting13
Active, not recruiting9
Unknown status7
Not yet recruiting4
Withdrawn4
Suspended3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic5
National Heart, Lung, and Blood Institute (NHLBI)5
Massachusetts General Hospital4
National Eye Institute (NEI)4
National Institute of Allergy and Infectious Diseases (NIAID)4
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)4
National Institute of Nursing Research (NINR)4
Novartis Pharmaceuticals4
Novo Nordisk A/S4
AstraZeneca3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation170
Pain11
Alzheimer Disease9
Atherosclerosis9
Cardiovascular Diseases9
Heart Failure8
Major Depressive Disorder8
Cognitive Dysfunction7
Crohn Disease7
Frailty7

Trials

Showing 1 to 25 of 170. Each trial links to its page on Pharma Observatory.

70 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.